279 related articles for article (PubMed ID: 12183587)
21. Low-Dose Exposure to Ganglioside-Mimicking Bacteria Tolerizes Human Macrophages to Guillain-Barré Syndrome-Associated Antigens.
Patry RT; Essler L; Andresen S; Quinn FD; Szymanski CM
mBio; 2021 Feb; 13(1):e0385221. PubMed ID: 35100875
[TBL] [Abstract][Full Text] [Related]
22. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.
Godschalk PC; Heikema AP; Gilbert M; Komagamine T; Ang CW; Glerum J; Brochu D; Li J; Yuki N; Jacobs BC; van Belkum A; Endtz HP
J Clin Invest; 2004 Dec; 114(11):1659-65. PubMed ID: 15578098
[TBL] [Abstract][Full Text] [Related]
23. Brucella melitensis infection associated with Guillain-Barré syndrome through molecular mimicry of host structures.
Watanabe K; Kim S; Nishiguchi M; Suzuki H; Watarai M
FEMS Immunol Med Microbiol; 2005 Aug; 45(2):121-7. PubMed ID: 16051063
[TBL] [Abstract][Full Text] [Related]
24. Identification of DNA sequence variation in Campylobacter jejuni strains associated with the Guillain-Barré syndrome by high-throughput AFLP analysis.
Godschalk PC; Bergman MP; Gorkink RF; Simons G; van den Braak N; Lastovica AJ; Endtz HP; Verbrugh HA; van Belkum A
BMC Microbiol; 2006 Apr; 6():32. PubMed ID: 16594990
[TBL] [Abstract][Full Text] [Related]
25. Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro.
Guerry P; Szymanski CM; Prendergast MM; Hickey TE; Ewing CP; Pattarini DL; Moran AP
Infect Immun; 2002 Feb; 70(2):787-93. PubMed ID: 11796612
[TBL] [Abstract][Full Text] [Related]
26. Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome.
Neisser A; Schwerer B; Bernheimer H; Moran AP
J Neuroimmunol; 2000 Jan; 102(1):85-8. PubMed ID: 10626671
[TBL] [Abstract][Full Text] [Related]
27. Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain-Barré syndrome?
Yuki N; Koga M; Hirata K
Acta Neurol Scand; 2000 Aug; 102(2):132-4. PubMed ID: 10949532
[TBL] [Abstract][Full Text] [Related]
28. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
Yuki N
Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
[TBL] [Abstract][Full Text] [Related]
29. The relationship of Campylobacter jejuni infection and the development of Guillain-Barré syndrome.
Tsang RS
Curr Opin Infect Dis; 2002 Jun; 15(3):221-8. PubMed ID: 12015454
[TBL] [Abstract][Full Text] [Related]
30. Ganglioside mimicry as a cause of Guillain-Barré syndrome.
Komagamine T; Yuki N
CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):391-400. PubMed ID: 16918391
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.
Koga M; Gilbert M; Takahashi M; Li J; Koike S; Hirata K; Yuki N
J Infect Dis; 2006 Feb; 193(4):547-55. PubMed ID: 16425134
[TBL] [Abstract][Full Text] [Related]
32. Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits.
Ang CW; Endtz HP; Jacobs BC; Laman JD; de Klerk MA; van der Meché FG; van Doorn PA
J Neuroimmunol; 2000 May; 104(2):133-8. PubMed ID: 10713352
[TBL] [Abstract][Full Text] [Related]
33. Development of an immunoassay for rapid detection of ganglioside GM(1) mimicry in Campylobacter jejuni strains.
Prendergast MM; Kosunen TU; Moran AP
J Clin Microbiol; 2001 Apr; 39(4):1494-500. PubMed ID: 11283076
[TBL] [Abstract][Full Text] [Related]
34. The sialic acid residue is a crucial component of C. jejuni lipooligosaccharide ganglioside mimicry in the induction Guillain-Barré syndrome.
Xiang SL; Zhong M; Cai FC; Deng B; Zhang XP
J Neuroimmunol; 2006 May; 174(1-2):126-32. PubMed ID: 16567003
[TBL] [Abstract][Full Text] [Related]
35. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
Yuki N; Susuki K; Koga M; Nishimoto Y; Odaka M; Hirata K; Taguchi K; Miyatake T; Furukawa K; Kobata T; Yamada M
Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11404-9. PubMed ID: 15277677
[TBL] [Abstract][Full Text] [Related]
36. Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes.
Houliston RS; Yuki N; Hirama T; Khieu NH; Brisson JR; Gilbert M; Jarrell HC
Biochemistry; 2007 Jan; 46(1):36-44. PubMed ID: 17198373
[TBL] [Abstract][Full Text] [Related]
37. Cross-reactive epitopes present in campylobacter jejuni serotypes isolated from enteritis patients.
Grozdanova A; Poceva-Panovska A; Brezovska K; Trajkovska-Dokic E; Dimovski A; Apostolski S; Suturkova Lj
Prilozi; 2011; 32(1):113-25. PubMed ID: 21822182
[TBL] [Abstract][Full Text] [Related]
38. TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation.
Kuijf ML; Samsom JN; van Rijs W; Bax M; Huizinga R; Heikema AP; van Doorn PA; van Belkum A; van Kooyk Y; Burgers PC; Luider TM; Endtz HP; Nieuwenhuis EE; Jacobs BC
J Immunol; 2010 Jul; 185(1):748-55. PubMed ID: 20525894
[TBL] [Abstract][Full Text] [Related]
39. Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner.
Bax M; Kuijf ML; Heikema AP; van Rijs W; Bruijns SC; García-Vallejo JJ; Crocker PR; Jacobs BC; van Vliet SJ; van Kooyk Y
Infect Immun; 2011 Jul; 79(7):2681-9. PubMed ID: 21502591
[TBL] [Abstract][Full Text] [Related]
40. [Pathogenesis of axonal Guillain-Barré syndrome].
Yuki N
Rinsho Shinkeigaku; 2007 Jan; 47(1):1-7. PubMed ID: 17491330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
